Your browser doesn't support javascript.
loading
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity.
Langdon, Sophie; Hughes, Adina; Taylor, Molly A; Kuczynski, Elizabeth A; Mele, Deanna A; Delpuech, Oona; Jarvis, Laura; Staniszewska, Anna; Cosulich, Sabina; Carnevalli, Larissa S; Sinclair, Charles.
Afiliación
  • Langdon S; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Hughes A; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Taylor MA; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Kuczynski EA; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Mele DA; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Waltham, MA, USA.
  • Delpuech O; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Jarvis L; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Staniszewska A; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Cosulich S; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Carnevalli LS; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Sinclair C; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
Oncoimmunology ; 7(8): e1458810, 2018.
Article en En | MEDLINE | ID: mdl-30221055

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido